Zobrazeno 1 - 10
of 892
pro vyhledávání: '"Valachis A"'
Autor:
Lampropoulos, Konstantinos, Kosmidis, Thanos, Autexier, Serge, Savic, Milos, Athanatos, Manos, Kokkonidis, Miltiadis, Koutsouri, Tzortzia, Vizitiu, Anamaria, Valachis, Antonios, Padron, Miriam Quintero
The latest cancer statistics indicate a decrease in cancer-related mortality. However, due to the growing and ageing population, the absolute number of people living with cancer is set to keep increasing. This paper presents ASCAPE, an open AI infras
Externí odkaz:
http://arxiv.org/abs/2308.14390
Autor:
Valachis A, Nilsson C
Publikováno v:
Breast Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 21-35 (2015)
Antonis Valachis,1 Cecilia Nilsson2 1Centre for Clinical Research Sörmland, Uppsala University, Eskilstuna, Sweden; 2Center for Clinical Research, Västmanlands County Hospital, Västerås, Sweden Abstract: As the number of long-term breast cancer s
Externí odkaz:
https://doaj.org/article/ab8433f1ba2449d19c6062e18f76802a
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 48, Iss , Pp 100846- (2024)
Background: The benefit of prophylactic whole pelvis radiation therapy (WPRT) in prostate cancer has been debated for decades, with evidence based mainly on conventional fractionation targeting pelvic nodes. Aim: This retrospective cohort study aimed
Externí odkaz:
https://doaj.org/article/4aa5ba41de704828a17251c4c4821f5e
Autor:
Antonis Valachis, Henrik Lindman
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-3 (2024)
Decentralized clinical trials have gained in popularity over the last years due to their advantages related to broadening recruitment strategies and resource saving possibilities. As more clinical trials adopt decentralized strategies, it is essentia
Externí odkaz:
https://doaj.org/article/16d18d51b84544ac86c39957d0a90fc0
Publikováno v:
Breast, Vol 76, Iss , Pp 103741- (2024)
Background: The aim of this population-based cohort study was to investigate the impact of neoadjuvant chemotherapy (NACT) compared to adjuvant chemotherapy in prognosis among patients with HR+/HER2 negative breast cancer. Method: This population-bas
Externí odkaz:
https://doaj.org/article/c9f5f5385550455d807244e425bd9f1d
Autor:
Peeter Karihtala, Aglaia Schiza, Elena Fountzilas, Jürgen Geisler, Icro Meattini, Emanuela Risi, Laura Biganzoli, Antonios Valachis
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background and purpose: While the prevalence of older breast cancer patients is rapidly increasing, these patients are greatly underrepresented in clinical trials. We discuss barriers to recruitment of older patients to clinical trials and propose so
Externí odkaz:
https://doaj.org/article/7054a51862ab46378ff84b1e60247062
Autor:
Cecilia Olsson Ladjevardi, Anthoula Koliadi, Viktoria Rydén, Ali Inan El-Naggar, Evangelos Digkas, Antonios Valachis, Gustav J. Ullenhag
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionCheckpoint inhibitors (CPI) are widely used in cancer treatment with a potential of causing immune-related adverse events (IRAEs). Several studies have reported a positive correlation between development of IRAEs and improved survival out
Externí odkaz:
https://doaj.org/article/b3986559b97a4869a10c9b6cd7761d49
Publikováno v:
In Clinical and Translational Radiation Oncology September 2024 48
Publikováno v:
In Expert Systems With Applications 1 September 2024 249 Part A
Publikováno v:
In The Breast August 2024 76